BMC Clinical Pharmacology

Table 4 Injection-site reactions, by number of events (n = 30, safety population)

From: Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation

	Formulation			Overall
	A	B	C
Redness	12	7	8	27
Bruising	1	0	1	2
Itching	1	1	0	2
Swelling	0	0	0	0
Induration	0	0	0	0
Total	14	8	9	31

r-hGH, recombinant human growth hormone.
A = r-hGH liquid multi-dose, 5.83 mg/mL.
B = r-hGH liquid multi-dose, 8.0 mg/mL.
C = r-hGH freeze-dried 8.8 mg, reconstituted in 1.51 mL.

Back to article page